These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


378 related items for PubMed ID: 23632457

  • 1. BDNF overexpression in mouse hippocampal astrocytes promotes local neurogenesis and elicits anxiolytic-like activities.
    Quesseveur G, David DJ, Gaillard MC, Pla P, Wu MV, Nguyen HT, Nicolas V, Auregan G, David I, Dranovsky A, Hantraye P, Hen R, Gardier AM, Déglon N, Guiard BP.
    Transl Psychiatry; 2013 Apr 30; 3(4):e253. PubMed ID: 23632457
    [Abstract] [Full Text] [Related]

  • 2. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
    Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Repérant C, Guilloux JP, Coudoré F, Hen R, Gardier AM.
    Neuropharmacology; 2008 Nov 30; 55(6):1006-14. PubMed ID: 18761360
    [Abstract] [Full Text] [Related]

  • 3. Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex.
    Dawson LA, Nguyen HQ, Smith DL, Schechter LE.
    J Psychopharmacol; 2002 Jun 30; 16(2):145-52. PubMed ID: 12095073
    [Abstract] [Full Text] [Related]

  • 4. Loss of Adult 5-HT1A Autoreceptors Results in a Paradoxical Anxiogenic Response to Antidepressant Treatment.
    Turcotte-Cardin V, Vahid-Ansari F, Luckhart C, Daigle M, Geddes SD, Tanaka KF, Hen R, James J, Merali Z, Béïque JC, Albert PR.
    J Neurosci; 2019 Feb 20; 39(8):1334-1346. PubMed ID: 30552180
    [Abstract] [Full Text] [Related]

  • 5. Neuronal nitric oxide synthase alteration accounts for the role of 5-HT1A receptor in modulating anxiety-related behaviors.
    Zhang J, Huang XY, Ye ML, Luo CX, Wu HY, Hu Y, Zhou QG, Wu DL, Zhu LJ, Zhu DY.
    J Neurosci; 2010 Feb 17; 30(7):2433-41. PubMed ID: 20164327
    [Abstract] [Full Text] [Related]

  • 6. Regulator of G-protein signaling 6 (RGS6) promotes anxiety and depression by attenuating serotonin-mediated activation of the 5-HT(1A) receptor-adenylyl cyclase axis.
    Stewart A, Maity B, Wunsch AM, Meng F, Wu Q, Wemmie JA, Fisher RA.
    FASEB J; 2014 Apr 17; 28(4):1735-44. PubMed ID: 24421401
    [Abstract] [Full Text] [Related]

  • 7. Synergistic neurochemical and behavioural effects of acute intrahippocampal injection of brain-derived neurotrophic factor and antidepressants in adult mice.
    Deltheil T, Tanaka K, Reperant C, Hen R, David DJ, Gardier AM.
    Int J Neuropsychopharmacol; 2009 Aug 17; 12(7):905-15. PubMed ID: 19236729
    [Abstract] [Full Text] [Related]

  • 8. Rapid anxiolytic effects of a 5-HT₄ receptor agonist are mediated by a neurogenesis-independent mechanism.
    Mendez-David I, David DJ, Darcet F, Wu MV, Kerdine-Römer S, Gardier AM, Hen R.
    Neuropsychopharmacology; 2014 May 17; 39(6):1366-78. PubMed ID: 24287720
    [Abstract] [Full Text] [Related]

  • 9. Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain-derived neurotrophic factor, β-catenin and antidepressant-like effects.
    Pilar-Cuéllar F, Vidal R, Pazos A.
    Br J Pharmacol; 2012 Feb 17; 165(4b):1046-57. PubMed ID: 21627639
    [Abstract] [Full Text] [Related]

  • 10. The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other anxiolytic agents.
    Dekeyne A, Brocco M, Adhumeau A, Gobert A, Millan MJ.
    Psychopharmacology (Berl); 2000 Sep 17; 152(1):55-66. PubMed ID: 11041316
    [Abstract] [Full Text] [Related]

  • 11. The postnatal 5-HT1A receptor regulates adult anxiety and depression differently via multiple molecules.
    Ishikawa C, Shiga T.
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Aug 01; 78():66-74. PubMed ID: 28483674
    [Abstract] [Full Text] [Related]

  • 12. The absence of 5-HT4 receptors modulates depression- and anxiety-like responses and influences the response of fluoxetine in olfactory bulbectomised mice: Adaptive changes in hippocampal neuroplasticity markers and 5-HT1A autoreceptor.
    Amigó J, Díaz A, Pilar-Cuéllar F, Vidal R, Martín A, Compan V, Pazos A, Castro E.
    Neuropharmacology; 2016 Dec 01; 111():47-58. PubMed ID: 27586007
    [Abstract] [Full Text] [Related]

  • 13. Protein kinase Mζ is involved in the modulatory effect of fluoxetine on hippocampal neurogenesis in vitro.
    Wang YX, Zhang XR, Zhang ZJ, Li L, Xi GJ, Wu D, Wang YJ.
    Int J Neuropsychopharmacol; 2014 Sep 01; 17(9):1429-41. PubMed ID: 24679950
    [Abstract] [Full Text] [Related]

  • 14. Rapid reorganization of serotonin projections and antidepressant response to 5-HT1A-biased agonist NLX-101 in fluoxetine-resistant cF1ko mice.
    Vahid-Ansari F, Newman-Tancredi A, Fuentes-Alvarenga AF, Daigle M, Albert PR.
    Neuropharmacology; 2024 Dec 15; 261():110132. PubMed ID: 39208980
    [Abstract] [Full Text] [Related]

  • 15. The monoaminergic tripartite synapse: a putative target for currently available antidepressant drugs.
    Quesseveur G, Gardier AM, Guiard BP.
    Curr Drug Targets; 2013 Oct 15; 14(11):1277-94. PubMed ID: 24020973
    [Abstract] [Full Text] [Related]

  • 16. Brain-derived neurotrophic factor-deficient mice exhibit a hippocampal hyperserotonergic phenotype.
    Guiard BP, David DJ, Deltheil T, Chenu F, Le Maître E, Renoir T, Leroux-Nicollet I, Sokoloff P, Lanfumey L, Hamon M, Andrews AM, Hen R, Gardier AM.
    Int J Neuropsychopharmacol; 2008 Feb 15; 11(1):79-92. PubMed ID: 17559709
    [Abstract] [Full Text] [Related]

  • 17. The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A/C activity in the hippocampus.
    Bambico FR, Duranti A, Nobrega JN, Gobbi G.
    Eur Neuropsychopharmacol; 2016 Mar 15; 26(3):578-90. PubMed ID: 26747370
    [Abstract] [Full Text] [Related]

  • 18. Anxiolytic-like effect of lavender essential oil inhalation in mice: participation of serotonergic but not GABAA/benzodiazepine neurotransmission.
    Chioca LR, Ferro MM, Baretta IP, Oliveira SM, Silva CR, Ferreira J, Losso EM, Andreatini R.
    J Ethnopharmacol; 2013 May 20; 147(2):412-8. PubMed ID: 23524167
    [Abstract] [Full Text] [Related]

  • 19. Requirement of hippocampal DG nNOS-CAPON dissociation for the anxiolytic and antidepressant effects of fluoxetine.
    Shi HJ, Wu DL, Chen R, Li N, Zhu LJ.
    Theranostics; 2022 May 20; 12(8):3656-3675. PubMed ID: 35664081
    [Abstract] [Full Text] [Related]

  • 20. Preclinical and clinical characterization of the selective 5-HT(1A) receptor antagonist DU-125530 for antidepressant treatment.
    Scorza MC, Lladó-Pelfort L, Oller S, Cortés R, Puigdemont D, Portella MJ, Pérez-Egea R, Alvarez E, Celada P, Pérez V, Artigas F.
    Br J Pharmacol; 2012 Nov 20; 167(5):1021-34. PubMed ID: 22050051
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.